Greater Noida, India

Varshavekumar S Patil

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Varshavekumar S Patil: Innovator in Therapeutic Compounds

Introduction

Varshavekumar S Patil is a notable inventor based in Greater Noida, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents targeting adenosine receptors. With a total of 2 patents to his name, his work is paving the way for advancements in oncology treatments.

Latest Patents

Patil's latest patents include innovative compounds that serve as adenosine antagonists. The first patent focuses on heterocyclic compounds, specifically aminopyrazine compounds, which act as modulators of adenosine receptors. These compounds have potential therapeutic applications for diseases mediated through G-protein-coupled receptor signaling pathways, with a particular emphasis on oncology. The second patent involves 1,8-naphthyridinone compounds, which also function as modulators of adenosine receptors and may be utilized in similar therapeutic contexts.

Career Highlights

Varshavekumar S Patil is currently associated with Nuvation Bio Inc., where he continues to explore and develop innovative solutions in the pharmaceutical industry. His expertise in the field has positioned him as a valuable asset to his organization and the broader scientific community.

Collaborations

Patil collaborates with talented individuals such as Son Minh Pham and Jiyun Chen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Varshavekumar S Patil's work in developing adenosine receptor modulators highlights his commitment to advancing therapeutic options in oncology. His contributions are significant in the ongoing quest for effective treatments for complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…